Cargando…
Identification of Prognostic Biomarker Candidates Associated With Melanoma Using High-Dimensional Genomic Data
Survival of patients with metastatic melanoma varies widely. Melanoma is a highly proliferative, chemo-resistant disease. With the recent availability of immunotherapies such as checkpoint inhibitors, durable response rates have improved but are often still limited to 2–3 years. Response rates to tr...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473904/ https://www.ncbi.nlm.nih.gov/pubmed/34589115 http://dx.doi.org/10.3389/fgene.2021.707105 |